Life sciences news
-
Galapagos announces CHMP adoption of PRAC’s recommendation for Jyseleca® following extensive safety review of all JAK inhibitors
Friday November 11th 2022
Read more
-
Is Belgium becoming a hub for gene therapy?
Thursday November 10th 2022
Read more
-
The QbD Group acquires regulatory affairs and pharmacovigilance company EUDRAC Ltd to expand its services for pharmaceutical customers
Tuesday November 8th 2022
Read more
-
New Idylla™ EGFR study shows reduction of time-to-treatment by 48% for lung cancer patients
Tuesday November 8th 2022
Read more
-
BIO INX and Nanoscribe expand their partnership with the launch of HYDROBIO INX© N400, a new biocompatible high resolution bioink enabling live cell encapsulation
Tuesday November 8th 2022
Read more
-
How did human brains get so large?
Friday November 4th 2022
Read more
-
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
Friday November 4th 2022
Read more
-
InnoSer and Inficure Bio enter partnership to increase accessibility of translational liver inflammation & fibrosis mouse model
Friday October 28th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Indigo Diabetes incorporates fully owned subsidiary in the US and appoints Peter J. Devlin as President, Indigo Medical US Inc.
Thursday October 27th 2022
Read more
-
Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON)
Tuesday October 25th 2022
Read more
-
Bone Therapeutics to start a new Euronext equity story with a change of name to BioSenic, following the acquisition of a majority participation of Medsenic valued at EUR 40 million
Tuesday October 25th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
